Novartis announced today the availability in the US of the first shipments of Fluvirin influenza virus vaccine for the 2007/08 season.
Reclast? (zoledronic acid) Injection has been approved by the US Food and Drug Administration as the first and only once-yearly medicine for postmenopausal osteoporosis, offering an important new approach to the treatment of a bone disease affecting eight million women in the US.
Advanced supply contracts to provide the vaccine for a possible flu pandemic were today awarded by the Department of Health to pharmaceutical company GSK and Baxter Healthcare.
The U.S. Food and Drug Administration (FDA) is concerned that nursing infants may be at increased risk of morphine overdose if their mothers are taking codeine and are ultra-rapid metabolizers of codeine. The agency has reviewed all available information on this subject since a medical journal reported the death of a 13-day old breastfed infant who died from morphine overdose.
A major focus in the search for accountability in the US health care system is new reimbursement and benefit models that provide incentives better linked to positive health outcomes. A recent study found some valuable lessons from a model in Maine that tied some degree of risk and reward for both health care providers and employer/purchasers.
Sunday was a red-letter day for Karen and J.P. Jepp. The couple’s family grew from three to seven between the hours of 2:00 p.m. and 3:00 p.m.
Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the safety and efficacy of over-the-counter pediatric cough and cold medicines:
GlaxoSmithKline (GSK) announced that it has entered into an agreement with the UK Government to provide its pandemic influenza vaccine in the event of a flu pandemic. It is one of the largest contracts signed by GSK to date for its proprietary adjuvanted pandemic flu vaccine.
The U.S. Food and Drug Administration announced the approval of updated labeling for the widely used blood-thinning drug, Coumadin, to explain that people’s genetic makeup may influence how they respond to the drug.
Prescribing ambulatory oxygen in patients with chronic obstructive pulmonary disease improves exercise performance, but not the quality of their daily life unless they have resting hypoxemia, according to researchers in Toronto.